The Health Resources and Services Administration tells Inside Health Policy that drug makers that curb 340B discounts at contract pharmacies might prevent vulnerable people from getting affordable drugs and the agency is encouraging drug makers to continue the discounts -- but it cautions the agency can only take enforcement action if there is a violation of the statute. America’s Essential Hospitals is the latest group to call on HRSA and HHS to step in and stop recent moves by...